| Flucelvax Tetra, Injektionssuspension - | | 67482005 | | Vifor (International) Inc. | | Flucelvax Tetra, Injektionssuspension | | 04.05.2021 | | | | | 04.05.2021 | | Influenza, gereinigtes Antigen (J07BB02) | | | | WHO-DDD | | 03.05.2026 | | 08.08. | | | | 08.08. | | | | B | | | | Ja | | | | FI | | | | 9.58 | | Ja | | | | | | | | | 10% | | 26.85 | | FB | | | | 7680674820055 | | Impfstoffe | | | | |
| | Zusammensetzung | | haemagglutininum influenzae A (H3N2) (Virus Stamm A/Kansas/14/2017 (H3N2)-like: derived from A/Indiana/08/2018) 15 µg, haemagglutininum influenzae A (H1N1) (Virus Stamm A/Brisbane/02/2018 (H1N1)-like: derived from A/Idaho/07/2018) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Colorado/06/2017-like: reassortant from B/Iowa/06/2017 (Victoria lineage)) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Phuket/3073/2013-like: reassortant from B/Singapore/INFTT-16-0610/2016 (Yamagata lineage)) 15 µg, natrii chloridum, kalii chloridum, magnesii chloridum hexahydricum, natrii dihydrogenophosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.7 mg, kalium 0.1 mg, residui: polysorbatum 80, cetrimidum, propiolactonum. | | Packungsbestandteile | | Injektionssuspension | | | | | | | | Wirkstoffe | Stärke |
|---|
| Haemagglutininum Influenzae a (H1N1) (Virus Stamm A/brisbane/02/2018 (H1N1)-Like: Derived from A/idaho/07/2018) | 15µg / 0.5ml | | Haemagglutininum Influenzae a (H3N2) (Virus Stamm A/kansas/14/2017 (H3N2)-Like: Derived from A/indiana/08/2018) | 15µg / 0.5ml | | Haemagglutininum Influenzae b (Virus Stamm B/colorado/06/2017-Like: Reassortant from B/iowa/06/2017 (Victoria Lineage)) | 15µg / 0.5ml |
| | BAG: Wirkstoffe | Stärke |
|---|
| Influenza-hämagglutinin | 0.06 mg |
| | | | Hilfsstoffe | Stärke |
|---|
| Haemagglutininum Influenzae b (Virus Stamm B/phuket/3073/2013-Like: Reassortant from B/singapore/inftt-16-0610/2016 (Yamagata Lineage)) | 15µg / 0.5ml | | Kalium Chlorid | | | Kalium Dihydrogenophosphat | | | Magnesium Chlorid Hexahydrat | | | Natrium Chlorid | | | Natrium Dihydrogenophosphat Dihydrat | |
| |
| | Quelle | | Datum des Datenimports : 07.08.2024
Swissmedic-Registration :
Sequenz :
Präparatname :
Zulassungsinhaber: :
Produktgruppe :
Index Therapeuticus (BSV) :
Heilmittelcode :
Registrierungsdatum :
Gültig bis :
Packungsnummer :
Packungsgrösse :
Handelsform/Einheit :
Abgabekategorie :
Wirkstoffe :
Zusammensetzung :
| |
|
|
